spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  esomeprazole 

 HSMN NewsFeed - 27 Mar 2020
Cipla Receives Final Approval for Generic Version of AstraZeneca Pharmaceutical's Nexium(R) (Esomeprazole for Oral Suspension 10mg, 20mg and 40mg)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 10 Aug 2018
Nuvo Pharmaceuticals(TM) Announces Letter of Intent to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 27 Sep 2017
Perrigo Announces First-To-Market Launch of the OTC Store Brand Equivalent Of Nexium(R) 24HR Capsules
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 21 Aug 2017
Perrigo Announces Final FDA Approval and Settlement for the Store Brand OTC Equivalent of Nexium(R) 24HR Capsules
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 1 Jun 2015
POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Apr 2015
Horizon Pharma plc Receives FDA Fast Track Designation for ACTIMMUNE(R) in the Treatment of Friedreich's Ataxia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 30 Mar 2015
Horizon Pharma plc to Acquire Hyperion Therapeutics, Inc. for $46.00 per Share or $1.1 Billion in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Feb 2015
Horizon Pharma plc Submits Investigational New Drug Application for ACTIMMUNE(R) in the Treatment of Friedreich's Ataxia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 19 Nov 2013
Horizon Pharma Announces Agreement to Acquire U.S. Rights to VIMOVO(R) and Provides 2014 Guidance
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 18 Nov 2013
Merck’s New Drug Application for an Investigational Intravenous (IV) Formulation of NOXAFIL(R) (posaconazole) Receives FDA Priority Review
Biopharmaceuticals FDA Regulatory
 HSMN NewsFeed - 12 Jul 2011
POZEN Announces Tomas S. Bocanegra, M.D. as Head of Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 May 2011
Watson Acquires Specifar Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Feb 2011
POZEN Announces Addition to Commercial Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 May 2010
FDA Approved VIMOVO(TM) for Arthritis Patients at Risk of Developing NSAID-Associated Gastric Ulcers
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 9 Feb 2010
Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inhibitors With Plavix(R) (Clopidogrel Bisulfate)
Biopharmaceuticals
 HSMN NewsFeed - 7 Jan 2010
Teva Announces Settlement Agreements with AstraZeneca Regarding Generic Prilosec(R) and Nexium(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 14 Sep 2009
POZEN Names Elizabeth A. Cermak as Executive Vice President, Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 May 2009
AstraZeneca Secures Approval for Nexium (esomeprazole) In Peptic Ulcer Bleeding
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 4 May 2009
AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
Biopharmaceuticals
 HSMN NewsFeed - 29 Jan 2009
POZEN Informed by FDA That Endoscopic Gastric Ulcer Incidence Continues to Be an Acceptable Primary Endpoint
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Dec 2008
AstraZeneca Submits sNDA for NEXIUM(R) for the Short-Term Treatment of GERD in Infants 0 to 1 Year Old
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 18 Nov 2008
AstraZeneca Appoints Rich Fante as President of its U.S. Business
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Sep 2008
CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 5 Aug 2008
CASTLE Data Showed Boosted REYATAZ(R) (atazanavir sulfate) and Lopinavir/r Achieved Similar Results for Undetectable Viral Load in Treatment-Naive HIV-1 Infected Patients, Regardless of Gender
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 15 Apr 2008
Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation
Biopharmaceuticals Generics Litigation Distribution
 HSMN NewsFeed - 28 Feb 2008
FDA Approves NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 7 Feb 2008
Ranbaxy Receives Tentative Approval to Manufacture and Market Esomeprazole Magnesium DR Capsules
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 6 Feb 2008
CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 10 Dec 2007
FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
Biopharmaceuticals
 HSMN NewsFeed - 1 Nov 2007
Pozen Announces Trexima(TM) (Sumatriptan Succinate and Naproxen Sodium) Amended Response Accepted for Review by FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Oct 2007
Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 15 Oct 2007
POZEN Submits Response to Approvable Letter for Trexima(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Oct 2007
POZEN Plans to Submit Response to Approvable Letter For Trexima(TM) Within the Next Ten Days
Biopharmaceuticals
 HSMN NewsFeed - 10 Jan 2007
POZEN Names Gilda M. Thomas as Senior Vice President and General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Dec 2006
Pozen Expects to Submit Revised Response to Trexima(TM) (Sumatriptan/Naproxen Sodium) Approvable Letter by Year End
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Nov 2006
POZEN Submits Full Response to FDA Approvable Letter For Trexima(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Oct 2006
FDA Approves New Formulation for NEXIUM
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 12 Oct 2006
FDA Approves NEXIUM for the Treatment of Zollinger-Ellison Syndrome
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 22 May 2006
Study Investigates NEXIUM(R) Benefits Patients With Zollinger-Ellison Syndrome
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 22 May 2006
New Study Shows Erosive Esophagitis Healing Linked to Gastric Acid Control
Biopharmaceuticals Gastroenterology
Return to NewsFeed  

 Additional items found! 18

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 18 additional stories matching:
esomeprazole
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.